Dextrose shortage — US supply status & alternatives

Dextrose

ATC B05CX01

🇦🇺 AUST R 22881 · PHEBRA PTY LTD

In supply · Australia

In supply · 🇦🇺 Australia · short in🇨🇦 CA🇺🇸 US

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Dextrose
ATC level 5	B05CX01
ATC level 4	B05CX
Therapeutic category	Auto-created by FDA Drug Enforcement — Full Recall Database scraper

Controlled substance	No

Marketing-authorisation holders	COX PHARMACEUTICAL LIMITED, HIKMA PHARMACEUTICALS USA INC., PHEBRA PTY LTD, B. Braun Medical Inc.

Registrations on file	29

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

4 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Moderate concentration risk

Ingredion INCWeifang Shengtai Medicine CO LTDShandong Tianli Pharmaceutical CO LTDCspc Shengxue Glucose CO LTD

Manufacturing countries: United States, China · Source: FDA List of Drug Master Files

Recalls official enforcement reports

🇺🇸

DEXTROSE

B BRAUN MEDICAL INC · Apr 2026

Class IIdetails ↗

🇺🇸

Dextrose

Sentara Infusion Services · Dec 2022

Class IIdetails ↗

🇺🇸

Dextrose

RXQ Compounding LLC · June 2019

Class IIdetails ↗

🇺🇸

Dextrose

RXQ Compounding LLC · June 2019

Class IIdetails ↗

🇺🇸

Dextrose

Walgreens Infusion Services · Nov 2015

Class IIdetails ↗

🇺🇸

Dextrose

Walgreens Infusion Services · Nov 2015

Class IIdetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders29 registrations · 4 MA holders

Product	Strength	Form	Market	MA holder	Status
Glucose B.P	—	glucose	🇬🇧 GB	COX PHARMACEUTICAL LIMITED	Active
Clindamycin in	6mg/mL	injection	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
Clindamycin in	12mg/mL	injection	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
Clindamycin in	18mg/mL	injection	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
Labetalol HCl in Dextrose	1mg/mL	injection	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
Milrinone Lactate in Dextrose	200ug/mL	injection	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
OPHTHALMIC LABS DEXTROSE 50% Anhydrous glucose	50%	—	🇦🇺 AU	PHEBRA PTY LTD	Active
Dextrose	50mg/mL	injection	🇺🇸 US	B. Braun Medical Inc.	Active
Cefuroxime and Dextrose	750mg/50mL	injection	🇺🇸 US	B. Braun Medical Inc.	Active
Cefuroxime and Dextrose	1.5g/50mL	injection	🇺🇸 US	B. Braun Medical Inc.	Active
Cefoxitin and Dextrose	1g/50mL	injection	🇺🇸 US	B. Braun Medical Inc.	Active
Cefoxitin and Dextrose	2g/50mL	injection	🇺🇸 US	B. Braun Medical Inc.	Active
Ceftriaxone And Dextrose	1g/50mL	injection	🇺🇸 US	B. Braun Medical Inc.	Active
Ceftriaxone And Dextrose	2g/50mL	injection	🇺🇸 US	B. Braun Medical Inc.	Active
Cefepime Hydrochloride And Dextrose	1g/50mL	injection	🇺🇸 US	B. Braun Medical Inc.	Active

+14 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.